Ghrelin, a widely distributed peptide hormone, participates in a series of cancer progression (35); GHRL plays a vital role in carcinogenic potential, which was correlated with breast cancer, lung cancer, bladder cancer, and adrenal cancer (17–20). Here, GHRL is linked to breast cancer.